Intercure Ltd. (INCR)
TASE 
NASDAQ (NMS) Primary TASE Summary
INCR Chart
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company
InterCure Ltd. INCR has shown resilience in its H1 2024 performance despite facing significant challenges, according to equity research by Pablo Zuanic of Zuanic & Associates.
InterCure: A Cannabis Industry Leader Still Flying Under The Radar
InterCure is a leading pharmaceutical/medical cannabis company based in Israel and a global leader outside North America. Despite the damage the Hamas attack and the state of war in Israel caused, the company managed to sustain operations and present a positive 2023 ER. The company is entitled to full compensation from the Israeli government for the damage taken.
Intercure Ltd. Dividends
Intercure Ltd. Earnings
| 28 Aug 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
| 13 Dec 2024 Date | | - Cons. EPS | - EPS |
| 23 May 2024 Date | | - Cons. EPS | - EPS |
| 1 Apr 2024 Date | | - Cons. EPS | - EPS |
| 16 Nov 2023 Date | | 0.17 Cons. EPS | - EPS |
| 28 Aug 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
| 13 Dec 2024 Date | | - Cons. EPS | - EPS |
| 23 May 2024 Date | | - Cons. EPS | - EPS |
| 1 Apr 2024 Date | | - Cons. EPS | - EPS |
| 16 Nov 2023 Date | | 0.17 Cons. EPS | - EPS |
Intercure Ltd. (INCR) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Intercure Ltd. ever had a stock split?
Intercure Ltd. Profile
| Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Alexander Rabinovich CEO | TASE Exchange | IL0011063760 ISIN |
| IL Country | 320 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
InterCure Ltd. is a prominent player in the medical cannabis industry, extending its footprint beyond its home country Israel to serve international markets. Founded in 1994 and based in Herzliya, Israel, the company has carved a niche in researching, cultivating, producing, and distributing pharmaceutical-grade cannabis and cannabis-based products tailored for medical applications. Besides its core operations in the cannabis sector, InterCure Ltd. also places strategic investments in the biomed sector, reflecting its broader vision in healthcare and medical innovations.
Products and Services
- Dried Cannabis Inflorescences: These are high-quality cannabis flowers cultivated under stringent controls to ensure pharmaceutical-grade quality. Used primarily for their therapeutic properties, they serve patients who rely on medical cannabis for relief from various conditions.
- Cannabis Extract Mixed with Oil: This product combines potent cannabis extracts with carrier oils to enhance bioavailability and ease of use. It's designed for patients seeking precise dosage and a more convenient consumption method than traditional flower products.
Contact Information
